News Image

ARS Pharmaceuticals Announces OptumRx, Cigna Healthcare and Navitus Health Systems Add neffy® (Epinephrine Nasal Spray) to National Formularies, Further Expanding Coverage for Patients

Provided By GlobeNewswire

Last update: Feb 21, 2025

Approximately five months after launch, the inclusion of neffy on these three additional formularies has expanded access to half of all patients and caregivers managing Type 1 allergic reactions, bringing the total number of formulary platforms covering neffy to 30

Read more at globenewswire.com

ARS PHARMACEUTICALS INC

NASDAQ:SPRY (2/21/2025, 8:00:02 PM)

After market: 11.21 -0.03 (-0.27%)

11.24

-0.54 (-4.58%)



Find more stocks in the Stock Screener

Follow ChartMill for more